Long-Term Study Of Middle-Aged Mice Shows Resveratrol Improves Health And Mimics Some Benefits Of Dietary Restriction

 03.07.2008 17:16   medicalnewstoday.com

Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, is included among a research team that reported in today's online edition of Cell Metabolism that mice treated at middle-age to the end-of-life with resveratrol showed an overall health improvement, including improved bone health, a reduction in cataracts and cardiovascular dysfunction, and improved balance and motor coordination.

World Cardiology